JP2018501796A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501796A5 JP2018501796A5 JP2017534592A JP2017534592A JP2018501796A5 JP 2018501796 A5 JP2018501796 A5 JP 2018501796A5 JP 2017534592 A JP2017534592 A JP 2017534592A JP 2017534592 A JP2017534592 A JP 2017534592A JP 2018501796 A5 JP2018501796 A5 JP 2018501796A5
- Authority
- JP
- Japan
- Prior art keywords
- headpiece
- chemical
- oligonucleotide
- ligation
- functional group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 39
- 108091034117 Oligonucleotide Proteins 0.000 claims description 29
- 125000000524 functional group Chemical group 0.000 claims description 14
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims description 12
- 125000006850 spacer group Chemical group 0.000 claims description 11
- 150000004713 phosphodiesters Chemical class 0.000 claims description 8
- 238000009739 binding Methods 0.000 claims description 6
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 230000001588 bifunctional effect Effects 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- QMQZIXCNLUPEIN-UHFFFAOYSA-N 1h-imidazole-2-carbonitrile Chemical compound N#CC1=NC=CN1 QMQZIXCNLUPEIN-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 150000005829 chemical entities Chemical class 0.000 claims description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003607 modifier Substances 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- -1 pyridin-2-yldisulfanyl Chemical group 0.000 description 2
- TYJPSIQEEXOQLC-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoate Chemical compound CC(C)(C)OC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O TYJPSIQEEXOQLC-UHFFFAOYSA-N 0.000 description 1
- ASNTZYQMIUCEBV-UHFFFAOYSA-N 2,5-dioxo-1-[6-[3-(pyridin-2-yldisulfanyl)propanoylamino]hexanoyloxy]pyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCCCCNC(=O)CCSSC1=CC=CC=N1 ASNTZYQMIUCEBV-UHFFFAOYSA-N 0.000 description 1
- NUHRPLKTAAVHCZ-UHFFFAOYSA-N 3-[2-[2-[2-[2-(9h-fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCOCCOCCOCCOCCC(=O)O)C3=CC=CC=C3C2=C1 NUHRPLKTAAVHCZ-UHFFFAOYSA-N 0.000 description 1
- ZTCKUVQHKIMCLI-UHFFFAOYSA-N 3-[2-[2-[2-[2-[2-[2-[bis(4-methoxyphenyl)-phenylmethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile Chemical compound C1=CC(OC)=CC=C1C(OCCOCCOCCOCCOCCOCCOP(OCCC#N)N(C(C)C)C(C)C)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 ZTCKUVQHKIMCLI-UHFFFAOYSA-N 0.000 description 1
- IMRNWKAKFIGPOS-UHFFFAOYSA-N 3-[3-[bis(4-methoxyphenyl)-phenylmethoxy]propoxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile Chemical compound C1=CC(OC)=CC=C1C(OCCCOP(OCCC#N)N(C(C)C)C(C)C)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 IMRNWKAKFIGPOS-UHFFFAOYSA-N 0.000 description 1
- BMTZEAOGFDXDAD-UHFFFAOYSA-M 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium;chloride Chemical compound [Cl-].COC1=NC(OC)=NC([N+]2(C)CCOCC2)=N1 BMTZEAOGFDXDAD-UHFFFAOYSA-M 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- SSMVDPYHLFEAJE-UHFFFAOYSA-N 4-azidoaniline Chemical compound NC1=CC=C(N=[N+]=[N-])C=C1 SSMVDPYHLFEAJE-UHFFFAOYSA-N 0.000 description 1
- SBZDIRMBQJDCLB-UHFFFAOYSA-N 5-azidopentanoic acid Chemical compound OC(=O)CCCCN=[N+]=[N-] SBZDIRMBQJDCLB-UHFFFAOYSA-N 0.000 description 1
- TWUKMYQCZJTUIC-UHFFFAOYSA-N N-[6-[2-cyanoethyl-[di(propan-2-yl)amino]-dihydroxy-lambda5-phosphanyl]hexyl]-2,2,2-trifluoroacetamide Chemical class N#CCCP(O)(O)(N(C(C)C)C(C)C)CCCCCCNC(=O)C(F)(F)F TWUKMYQCZJTUIC-UHFFFAOYSA-N 0.000 description 1
- XGCXOESBTLLHKY-UHFFFAOYSA-N NC(=O)CCOCC#C Chemical compound NC(=O)CCOCC#C XGCXOESBTLLHKY-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Chemical class Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- HRLUZSSGBKDEGK-QMMMGPOBSA-N tert-butyl (2s)-2-(azidomethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC[C@H]1CN=[N+]=[N-] HRLUZSSGBKDEGK-QMMMGPOBSA-N 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462098037P | 2014-12-30 | 2014-12-30 | |
| US62/098,037 | 2014-12-30 | ||
| PCT/US2015/067667 WO2016109423A1 (en) | 2014-12-30 | 2015-12-28 | Methods for tagging dna-encoded libraries |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018501796A JP2018501796A (ja) | 2018-01-25 |
| JP2018501796A5 true JP2018501796A5 (enExample) | 2019-02-07 |
| JP6864621B2 JP6864621B2 (ja) | 2021-04-28 |
Family
ID=56284965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017534592A Expired - Fee Related JP6864621B2 (ja) | 2014-12-30 | 2015-12-28 | Dnaコード化ライブラリーをタグ付けするための方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20180002688A1 (enExample) |
| EP (1) | EP3240795A4 (enExample) |
| JP (1) | JP6864621B2 (enExample) |
| KR (1) | KR20170094445A (enExample) |
| CN (1) | CN107428795B (enExample) |
| AU (2) | AU2015374309B2 (enExample) |
| BR (1) | BR112017013904A2 (enExample) |
| CA (1) | CA2972275A1 (enExample) |
| EA (1) | EA201791312A1 (enExample) |
| HK (1) | HK1246301A1 (enExample) |
| IL (2) | IL253154B (enExample) |
| MA (1) | MA41298A (enExample) |
| MX (1) | MX2017008772A (enExample) |
| SG (1) | SG11201705350XA (enExample) |
| WO (1) | WO2016109423A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017218293A1 (en) | 2016-06-16 | 2017-12-21 | Richard Edward Watts | Oligonucleotide directed and recorded combinatorial synthesis of encoded probe molecules |
| WO2018195134A1 (en) * | 2017-04-18 | 2018-10-25 | X-Chem, Inc. | Methods for identifying compounds |
| WO2018204420A1 (en) | 2017-05-02 | 2018-11-08 | Haystack Sciences Corporation | Molecules for verifying oligonucleotide directed combinatorial synthesis and methods of making and using the same |
| US11384376B2 (en) * | 2018-05-31 | 2022-07-12 | Roche Molecular Systems, Inc. | Reagents and methods for post-synthetic modification of nucleic acids |
| CN110658163A (zh) * | 2018-06-29 | 2020-01-07 | 成都先导药物开发股份有限公司 | 一种合成dna编码化合物中的反应监测方法 |
| CN109468310B (zh) * | 2018-10-25 | 2020-12-01 | 深圳劲宇生物科技有限公司 | Dna编码碎片分子库的合成方法和连接基团的筛选方法 |
| JP7646212B2 (ja) * | 2019-03-14 | 2025-03-17 | ヘイスタック サイエンシーズ コーポレイション | オリゴヌクレオチドコード化分子を加工または分析する方法および系 |
| WO2021115319A1 (zh) * | 2019-12-10 | 2021-06-17 | 成都先导药物开发股份有限公司 | 同时结合多个生物靶标的dna编码化合物库筛选方法 |
| EP4240863A4 (en) * | 2020-11-06 | 2025-03-12 | The University of Chicago | HAIRPIN OLIGONUCLEOTIDES AND THEIR USES |
| WO2025053257A1 (ja) * | 2023-09-07 | 2025-03-13 | 旭化成ファーマ株式会社 | オリゴヌクレオチドによりコード化された化合物の製造方法、およびその応用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996038726A1 (en) * | 1995-05-30 | 1996-12-05 | Ecole Polytechnique Federale De Lausanne (Epfl) | Covalently immobilized phospholipid bilayers on solid surfaces |
| CN106337046B (zh) * | 2002-10-30 | 2021-03-23 | 纽韦卢森公司 | 合成双功能复合物的方法 |
| JP5646127B2 (ja) * | 2003-12-17 | 2014-12-24 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC | コードされたライブラリーの合成のための方法 |
| US8846883B2 (en) * | 2011-08-16 | 2014-09-30 | University Of Southhampton | Oligonucleotide ligation |
| SG10201605812YA (en) * | 2011-09-07 | 2016-09-29 | Chem Inc X | Methods for tagging dna-encoded libraries |
| KR102146721B1 (ko) * | 2012-07-13 | 2020-08-21 | 엑스-켐, 인크. | 폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리 |
-
2015
- 2015-12-27 MA MA041298A patent/MA41298A/fr unknown
- 2015-12-28 JP JP2017534592A patent/JP6864621B2/ja not_active Expired - Fee Related
- 2015-12-28 HK HK18105560.9A patent/HK1246301A1/zh unknown
- 2015-12-28 MX MX2017008772A patent/MX2017008772A/es unknown
- 2015-12-28 US US15/540,284 patent/US20180002688A1/en not_active Abandoned
- 2015-12-28 AU AU2015374309A patent/AU2015374309B2/en not_active Ceased
- 2015-12-28 EA EA201791312A patent/EA201791312A1/ru unknown
- 2015-12-28 CN CN201580077171.7A patent/CN107428795B/zh not_active Expired - Fee Related
- 2015-12-28 SG SG11201705350XA patent/SG11201705350XA/en unknown
- 2015-12-28 EP EP15876097.5A patent/EP3240795A4/en not_active Withdrawn
- 2015-12-28 WO PCT/US2015/067667 patent/WO2016109423A1/en not_active Ceased
- 2015-12-28 CA CA2972275A patent/CA2972275A1/en active Pending
- 2015-12-28 KR KR1020177019616A patent/KR20170094445A/ko not_active Withdrawn
- 2015-12-28 BR BR112017013904-9A patent/BR112017013904A2/pt active Search and Examination
-
2017
- 2017-06-25 IL IL253154A patent/IL253154B/en active IP Right Grant
-
2020
- 2020-09-11 AU AU2020230345A patent/AU2020230345A1/en not_active Withdrawn
- 2020-10-18 IL IL278117A patent/IL278117A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018501796A5 (enExample) | ||
| Whitfield et al. | Functional DNA–polymer conjugates | |
| CN106540268B (zh) | 一种TDNs-AS1411-核酸药物复合纳米材料载药系统及其制备方法 | |
| JP2022017453A5 (enExample) | ||
| KR102124613B1 (ko) | Dna-코딩된 라이브러리에 태그부착하는 방법 | |
| KR102146721B1 (ko) | 폴리머라제에 의해 판독가능하지 않은 코딩 올리고뉴클레오티드 연결을 갖는 dna-코딩된 라이브러리 | |
| JP2016533760A5 (enExample) | ||
| KR20200035937A (ko) | T 세포의 기능을 조절하기 위한 안티센스 올리고뉴클레오티드 | |
| JP6864621B2 (ja) | Dnaコード化ライブラリーをタグ付けするための方法 | |
| JP2019517268A5 (enExample) | ||
| JP2019516378A5 (enExample) | ||
| WO2005080567A1 (de) | Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren | |
| WO2023141474A9 (en) | Poly-tailed and poly-capped mrna and uses thereof | |
| RU2020130258A (ru) | Способ получения шпилечной одноцепочечной молекулы рнк | |
| EA201691786A1 (ru) | Композиции олигонуклеотидов и способы их получения | |
| CN113728102A (zh) | 使用剪接调节化合物进行新抗原工程化 | |
| TWI606058B (zh) | Nucleic acid complex and nucleic acid polysaccharide complex | |
| KR20140044324A (ko) | 페길화된 올리고뉴클레오티드의 제조방법 | |
| JPWO2023039586A5 (enExample) | ||
| AU2018231559A1 (en) | Extracellular matrix-producing composition using MAST4 gene and preparation method therefor | |
| KR101801958B1 (ko) | siRNA의 종양 표적화된 전달을 위한 siRNA 다량체-글리콜 키토산 나노복합체 및 이의 제조방법 | |
| Patwa et al. | Tuning molecular interactions in lipid-oligonucleotides assemblies via locked nucleic acid (LNA)-based lipids | |
| CN118715317A (zh) | Dna聚合酶介导的基因组编辑 | |
| JPWO2023086834A5 (enExample) | ||
| Williams et al. | 85 Developing a new generation of peptidyl-oligonucleotide conjugates with desired biocatalytic properties against biologically relevant RNA |